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Summary
Most bacterially produced antimicrobial peptides
(bacteriocins) are thought to kill target cells by a
receptor-mediated mechanism. However, for most
bacteriocins the receptor is unknown. For instance, no
target receptor has been identified for the two-peptide
bacteriocins (class IIb), whose activity requires the
combined action of two individual peptides. To identify
the receptor for the class IIb bacteriocin lactococcin
G, which targets strains of Lactococcus lactis, we
generated 12 lactococcin G-resistant mutants and per-
formed whole-genome sequencing to identify muta-
tions causing the resistant phenotype. Remarkably, all
had a mutation in or near the gene uppP (bacA), encod-
ing an undecaprenyl pyrophosphate phosphatase; a
membrane protein involved in peptidoglycan synthe-
sis. Nine mutants had stop codons or frameshifts in
the uppP gene, two had point mutations in putative
regulatory regions and one caused an amino acid
substitution in UppP. To verify the receptor function of
UppP, it was shown that growth of non-sensitive Strep-
tococcus pneumoniae could be inhibited by lactococ-
cin G when L. lactis uppP was expressed in this
bacterium. Furthermore, we show that the related
class IIb bacteriocin enterocin 1071 also uses UppP as
receptor. The approach used here should be broadly
applicable to identify receptors for other bacteriocins
as well.
Introduction
Lactic acid bacteria (LAB) produce a large variety of bac-
teriocins (ribosomally synthesized antimicrobial peptides
from bacteria), which kill target bacteria by permeabilizing
their plasma membrane (Nissen-Meyer et al., 2009; Cotter
et al., 2013). Many of these bacteriocins do not, however,
act directly on the membrane lipids, but rather on specific
membrane proteins, i.e. via a receptor-mediated process
(Ramnath et al., 2000; Héchard and Sahl, 2002; Diep
et al., 2007; Gabrielsen et al., 2012; Uzelac et al., 2013).
Particularly the unmodified bacteriocins of class II [com-
prising the pediocin-like bacteriocins (class IIa), the two-
peptide bacteriocins (class IIb), the cyclic bacteriocins
(class IIc) and the linear non-pediocin-like bacteriocins
(class IId) (Cotter et al., 2013)] seem to require such mem-
brane localized proteins for their activity. The nature of the
pore formed after bacteriocin-receptor binding is not char-
acterized, but in some cases circumstantial evidence sug-
gests that binding of the bacteriocin to the receptor may
change the conformation of the receptor, which then leads
to membrane leakage (Diep et al., 2007; Kjos et al., 2010).
Through this receptor-mediated mode of action, bacterioc-
ins show antimicrobial activity at very low – nanomolar to
picomolar – concentrations, and the specific receptor rec-
ognition also determines the inhibitory spectra of the dif-
ferent bacteriocins.
In order to protect themselves from self-killing,
bacteriocin-synthesizing cells produce immunity proteins.
In some cases, such immunity proteins have been
shown to prevent membrane leakage by binding to the
bacteriocin-receptor complex (Diep et al., 2007).Adetailed
understanding of the mode of action of bacteriocins
will thus involve delineating the molecular interactions
between a bacteriocin, its receptor and the immunity
protein. A bacteriocin’s cognate immunity protein is gener-
ally encoded in the same operon as the bacteriocin (van
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Belkum et al., 1991; Cotter et al., 2013) and can thus be
easily identified by DNA sequencing and analysis of the
operon region. Identification of the receptor on target cells
is, on the other hand, not trivial, and only a few such
bacteriocin receptors have been identified to date. The
membrane-embedded IIC and IID subunits of the mannose
phosphotransferase system have been shown to act as
receptor for the pediocin-like (class IIa) bacteriocins, first
circumstantially by genetic analysis (Ramnath et al., 2000;
2004; Gravesen et al., 2002; Héchard and Sahl, 2002) and
then conclusively by immunoprecipitation where a physical
association between these bacteriocins, their immunity
proteins and the IIC and IID subunits of the mannose
phosphotransferase was established (Diep et al., 2007).
Interestingly, the mannose phosphotransferase system
also functions as the receptor for lactococcin A, a class IId
LAB bacteriocin that is very different from the pediocin-like
bacteriocins (Diep et al., 2007), as well as for microcin
E492, a bacteriocin targeting various Enterobacteriaceae
species (Bieler et al., 2006). Membrane-located target pro-
teins have also been identified for the class IIc bacteriocin
garvicin ML and the class IId bacteriocin LsbB; the former
targets the maltose ABC transporter (Gabrielsen et al.,
2012) and the latter targets a metallopeptidase known as
YvjB (Uzelac et al., 2013). Due to their narrow inhibitory
spectrum and high potency, it has been hypothesized
that even the two-peptide (class IIb) bacteriocins target
specific proteins in the membrane of sensitive bacteria
(Nissen-Meyer et al., 2010), but no receptor has yet been
identified for any of these bacteriocins.
Lactococcin G was the first two-peptide bacteriocin to
be isolated (Nissen-Meyer et al., 1992) and is presently
the best-characterized bacteriocin in class IIb. The class
now includes at least 15 other bacteriocins, among
these are enterocin 1071 (Balla et al., 2000; Franz et al.,
2002; Balla and Dicks, 2005) and lactococcin Q (Zendo
et al., 2006) that have, respectively, 57% and 88%
sequence identity with lactococcin G (Oppegård et al.,
2007). As the name indicates, all two-peptide (class IIb)
bacteriocins consist of two different peptides whose
genes are located next to each other in the same
operon, and both peptides must be present in approxi-
mately equal molar amounts to obtain optimal antibac-
terial activity (Moll et al., 1996; 1998; 1999; reviewed
in Oppegård et al., 2007; Nissen-Meyer et al., 2010).
Lactococcin G consists of the 39-residue alpha-peptide
and the 35-residue beta-peptide (Nissen-Meyer et al.,
1992). These two peptides interact upon exposure to
membrane-like entities (Hildeng-Hauge et al., 1998) and
appear to form a membrane-penetrating helix–helix
structure stabilized by helix–helix-interacting GxxxG-
motifs upon contact with sensitive bacteria (Oppegård
et al., 2008; 2010; Rogne et al., 2008). This motif is
found in all two-peptide bacteriocins that have currently
been sequenced (Nissen-Meyer et al., 2010), and it has
been proposed that the two peptides of many, if not all,
two-peptide bacteriocins form a membrane-penetrating
helix–helix structure that interacts with an integrated
membrane protein in sensitive bacteria. Attempts to
identify such a target protein for lactococcin G by utiliz-
ing a similar immunoprecipitation approach as used to
identify the receptors for lactococcin A and the pediocin-
like bacteriocins have, however, not succeeded (D.B.
Diep et al., unpubl. results).
Here we present an alternative way of identifying puta-
tive bacteriocin receptors by the use of whole-genome
sequencing of spontaneous mutants of sensitive cells that
have gained resistance to lactococcin G and enterocin
1071. Genome comparisons of wild-type L. lactis with 12
independent mutants resulted in an unequivocal identifica-
tion of UppP/BacA, a undecaprenyl pyrophosphate phos-
phatase involved in cell-wall synthesis, as the putative
receptor for these two bacteriocins. Heterologous expres-
sion of uppP in the non-sensitive Streptococcus pneumo-
niae turned this bacterium sensitive to both lactococcin G
and enterocin 1071. The approach of whole-genome
sequencing of bacteriocin-resistant mutants combined
with heterologous expression should be a widely applica-
ble method for identification of receptors also for other
bacteriocins.
Results
Generation of lactococcin G-resistant mutants
An approach which previously has been successful for
identification of bacteriocin receptors involves generation
of resistant mutants and subsequent phenotypic (sugar
fermentation profiling) and genotypic (PCR and DNA
sequencing) analyses to identify the alterations responsi-
ble for the acquired resistance (Gabrielsen et al., 2012).
Therefore, we generated lactococcin G-resistant strains
by exposing sensitive strains of Lactococcus lactis
(IL1403 and MG1363) to lactococcin G on GM17 agar
plates. Ten lactococcin G-resistant mutants of L. lactis
IL1403 and two lactococcin G-resistant mutants of L.
lactis subsp. cremoris MG1363 were isolated (see
Experimental procedures and Table 1). Seven out of the
10 mutant IL1403 strains were resistant to the highest
lactococcin G concentration tested (Table 1). The remain-
ing three strains (IL3, IL5 and IL7) were less resistant, but
still highly resistant compared to the wild-type strain. The
two MG1363-derived mutant strains were both resistant
to the highest lactococcin G concentration tested
(Table 1).
All the mutant strains were also assayed against the
lactococcin G-like two-peptide bacteriocin enterocin 1071,
which has 57% sequence identity with lactococcin G.
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Overall, the degree of resistance to enterocin 1071 was
similar to what was observed for lactococcin G (Table 1);
all the mutants were resistant to the highest enterocin
1071 concentration tested, except the strain IL5. These
results suggest that the same genetic determinant(s) are
involved in the sensitivity to lactococcin G and the related
bacteriocin enterocin 1071.
Lactococcin G-resistance does not cause changes in
carbohydrate fermentation
Several class II bacteriocins have been shown to target
sugar transporters in the membrane of sensitive cells and
mutants resistant to such bacteriocins show an altered
sugar fermentation pattern compared to their wild-type
counterparts (Kjos et al., 2011; Gabrielsen et al., 2012). In
the regular growth medium (M17 supplemented with
glucose), the growth rate of the resistant mutants was
similar to that of the wild-type cells, except for a slightly
extended lag phase for the mutants (Fig. 1). In order to
examine if the mutants differed in growth on other sugars,
we compared the carbohydrate fermentation profiles of
the wild-type and two resistant mutants (IL11 and IL12)
using the API fermentation kit, which allows us to test 49
different carbohydrates simultaneously. However, no dif-
ferences were observed between the wild-type and the
resistant mutants, suggesting that, unlike several other
class II bacteriocins (pediocin-like, lactococcin A, garvicin
ML), the target receptor for lactococcin G is probably not
involved in any sugar metabolism pathway.
Lactococcin G-resistant mutants contain mutations in a
gene coding for a membrane protein involved in
peptidoglycan synthesis
Since we did not observe any clear phenotype of our
lactococcin G-resistant mutants, we performed whole-
genome sequencing of the resistant mutants to see if we
could identify bacteriocin receptors based on mutations in
the genome. As a proof of principle, we first tested this
method on an already characterized bacteriocin system;
lactococcin A is one of the class II bacteriocins for which
the receptor proteins in the membrane of target cells have
already been identified, namely the IIC and IID subunits of
the mannose phosphotransferase system (Diep et al.,
2007; Kjos et al., 2009). Two mutants of L. lactis IL1403
that are partially resistant to lactococcin A (30-fold
increased resistance) were isolated and whole-genome
sequencing was performed. Remarkably, the only change
from the wild-type was that each of the mutants contained
one mutation in the receptor genes (one in ptnC resulting
in the substitution G188A in the mannose phosphotrans-
ferase IIC subunit and the other in ptnD resulting in P115H
in the IID subunit, see Supporting information for details),
thus clearly demonstrating that whole-genome sequenc-
ing of resistant mutants can be used to pinpoint bacteri-
ocin receptors.
Knowing that bacteriocin receptors can be identified
using this method, we sequenced all the 10 lactococcin
G-resistant mutants derived from the sensitive wild-type
strain L. lactis IL1403 as well as the two mutants derived
Table 1. Spontaneous mutants resistant to lactococcin G (LcnG) and enterocin 1071 (Ent1071).
Strain
MIC (nM) ± st.dev





sequence Genetic consequence of mutationLcnG Ent1071 LcnG Ent1071
IL1403 (wt) 0.01 ± 0.01 0.05 ± 0.01 1 1 – –
IL1 > 25 > 25 > 2500 > 500 2 275 477 GAA to TAA: E191Stop in uppP
IL2 > 25 > 25 > 2500 > 500 2 275 894 GGA to TGA: G53Stop in uppP
IL3 20 ± 2 > 25 2000 > 500 2 276 047 GAT to AAT: D2N in uppP
IL4 > 25 > 25 > 2500 > 500 2 275 631 TGG to TGA: W140Stop in uppP
IL5 7 ± 3 3 ± 1 700 60 2 276 128 T to G 77 nucleotides upstream of
translation start in uppP
IL6 > 25 > 25 > 2500 > 500 2 276 059 G to T 9 nucleotides upstream of
translation start in uppP
IL7 18 ± 1 > 25 1800 > 500 2 275 292 TAT to TAG: Y253Stop in uppP
IL8 > 25 > 25 > 2500 > 500 2 275 369 CAA to TAA: Q228Stop in uppP
IL11 > 25 > 25 > 2500 > 500 2 275 812 ACC to A-C: frameshift at T80 in uppP
leading to loss of 199 amino acids
IL12 > 25 > 25 > 2500 > 500 2 275 997 TGG to TGA: W18Stop in uppP
MG1363 (wt) 0.02 ± 0.01 0.11 ± 0.03 1 1 – –
MG1 > 25 > 25 > 1250 > 225 2 432 943 CAA to C-A: frameshift at Q85 in bacA
leading to loss of 199 amino acids
MG2 > 25 > 25 > 1250 > 225 2 432 965 CAA to TAA: Q78Stop in bacA
684 550 GAA to AAA: E338K in oppD
MIC values, fold increase of bacteriocin resistance, position of differences relative to the Genbank reference genome (NC_002662) and genetic
consequence of mutation are indicated.
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from the sensitive strain L. lactis MG1363 (about 18 million
reads per genome, 2 × 100 nt paired-end reads). Both of
the wild-type strains (IL1403 and MG1363) were also
sequenced to identify differences between our lab strains
and the sequences in the databases. Indeed, our
sequence analysis detected 170 differences between our
wild-type IL1403 strain and the Genbank sequence
NC_002662 (Table S3). Our MG1363 wild-type strain
differed from the Genbank reference sequence
(NC_009004) in 75 positions (Table S4). Most of these
differences probably represent real changes that have
accumulated in the strains during the time they have spent
in different labs (Fig. S3), although some differences may
represent sequencing errors in the database sequence
(see Supporting information for details).
The genome sequences of the lactococcin G-resistant
strains showed that each of the 10 resistant strains derived
from IL1403 contained one single point mutation in their
genomes compared to the wild-type reference. Most
notably, all of these point mutations were located in or near
the gene uppP (locus tag L58643) encoding undecaprenyl
pyrophosphate phosphatase, UppP, a membrane located
protein involved in peptidoglycan synthesis (El Ghachi
et al., 2004). Furthermore, each of the two lactococcin
G-resistant mutants derived from strain MG1363 (MG1 and
MG2) also contained a single point mutation in the ortholo-
gous gene encoding undecaprenyl pyrophosphate phos-
phatase (named bacA in the annotated MG1363 genome
sequence, locus tag llmg_2476). The proteins from IL1403
(UppP) and MG1363 (BacA) are 96.8% identical. In addi-
tion to the mutations in bacA, one of the resistant strains
(MG2) had a codon change in the penultimate position of
oppD (locus-tag llmg_0697), the ATPase component of an
ABC-type dipeptide/oligopeptide/nickel transport system.
However, it is very unlikely that this mutation is linked with
lactococcin G resistance, since this gene was intact in the
other resistant mutants. The mutations in the resistant
strains are summarized in Table 1. In nine out of the 12
mutants, the uppP/bacA gene was truncated, due to either
insertions/deletions causing frameshifts or introduction of
stop codons within the gene. One of the strains contained
a single point mutation inside uppP (IL3), while two strains
(IL5 and IL6) contained mutations in the putative regulatory
region of uppP. The position of the truncations relative to
the predicted transmembrane helices and intra- and extra-
cellular regions of UppP are shown in Fig. 2A, and the
positions of the latter three mutations in the uppP upstream
sequence are shown in Fig. 2B.
The transcription of uppP is reduced in the
mutant strain IL5
The expression of uppP in the two mutants harbouring
mutations in putative regulatory regions of uppP (IL5 and
IL6) and the mutant with the point mutation leading to a
D2N substitution in UppP (IL3) was analysed by quanti-
tative PCR (qPCR). When compared to the wild-type
strain, no significant change in the transcription level of
uppP was observed in IL3 and IL6. In IL5, however, a
20-fold reduction in uppP expression was observed
(Fig. 3). Presence (0.5 nM) or absence of lactococcin G
had no significant effect on uppP expression in any of the
strains (results not shown).
Inactivation of uppP does not have a major impact on
cell growth and sensitivity to bacitracin and nisin
As mentioned above, the growth rate of UppP-inactivated
mutants was similar to that of wild-type cells, except for a
slightly extended lag phase for the mutants (Fig. 1). Also,
no differences between wild-type and mutants were
observed with phase-contrast microscopy (data not
shown). Moreover, inactivation of UppP did not have a
major impact on the sensitivity of the cells to bacitracin, an
antibiotic that targets the substrate of UppP (undecapre-
Fig. 1. Growth of L. lactis IL1403 and the derived lactococcin
G-resistant mutants IL11 and IL12 in normal growth medium GM17
(A) and in GM17 containing lactococcin G (amount corresponding
to 20× wild-type MIC) (B).
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nyl pyrophosphate) (Storm and Strominger, 1973). Nor
did it alter the sensitivity to nisin, a bacteriocin that targets
the lipid II component of the cell-wall (Breukink et al.,
1999) (data not shown). Taken together, this suggests that
inactivation of UppP does not have a detrimental effect on
cell-wall synthesis and the viability of L. lactis.
Heterologous expression of wild-type uppP gene from L.
lactis makes S. pneumoniae sensitive to lactococcin G
We repeatedly attempted to ectopically express uppP in
the L. lactis wild-types and in the resistant mutants (using
different cloning vectors) in order to further verify the
involvement of UppP in sensitivity to lactococcin G.
However, for unknown reasons, we were not able to rein-
troduce this gene. Therefore, we tried a different approach
and wondered if expression of L. lactis uppP in a heterolo-
gous host that is otherwise resistant to lactococcin G could
render this strain sensitive. To test this, we introduced the
lactococcal uppP in S. pneumoniae, another lactic acid
bacterium that is insensitive to lactococcin G. Indeed, the
S. pneumoniae strain used, D39, was resistant to the
highest lactococcin G concentration tested (3 μM, which is
300 000-fold higher than the MIC value for L. lactis
IL1403). A single copy of uppP downstream of a Zn2+-
inducible promoter was integrated into the genome of S.
pneumoniae D39, resulting in strain S. pneumoniae
MK194. In line with our hypothesis, expression of the
lactococcal uppP in S. pneumoniae D39 conferred lacto-
coccin G sensitivity, and the level of sensitivity correlated
with the uppP expression level (Fig. 4); S. pneumoniae
MK194 was only inhibited by lactococcin G when expres-
sion of uppP was induced by the addition of increasing
amounts of Zn2+ to the growth medium (Fig. 4). The pres-
ence of the inducer (Zn2+) at the concentrations used did
not alter the growth of S. pneumoniae (Fig. 4B). Both
wild-type S. pneumoniae D39 and uninduced strain MK194
were resistant to the highest lactococcin G concentrations
tested (MIC > 3000 nM, Table S1), but induction of MK194
with 0.2 mM Zn2+ made this strain more than 50-fold more
Fig. 2. Position of mutations in or near uppP.
A. Schematic overview of the mutants containing truncated uppP gene products due to frameshift mutations or introduction of stop-codons.
The top panel shows an outline of UppP with transmembrane helices (black boxes), intracellular loops (red) and extracellular loops (blue) as
predicted by TMHMM v 2.0 (Krogh et al., 2001), and the green line show the length of the truncated UppP variants.
B. Two of the mutations mapped in the putative regulatory region of uppP (IL5 and IL6). The mutation in IL3 mapped to the second codon of
uppP, causing an amino acid substitution (D2N). The promoter region was predicted using PPP (E-value = 0.056) (Zomer et al., 2007) and is
marked in blue, with the putative −35 and −10 regions underlined. The putative ribosome binding site (RBS) is marked in red.
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sensitive to lactococcin G (MIC = 56 nM). To further verify
that the induced sensitivity to lactococcin G was specifi-
cally due to expression of uppP, and not a general
response to membrane protein overexpression, we also
expressed the membrane-associated protein GFP-Pbp2x
(Peters et al., 2014) from the same Zn2+-inducible pro-
moter, and showed that this did not influence the lactococ-
cin G sensitivity of S. pneumoniae (Fig. S1). Moreover,
expression of uppP increased the sensitivity of the recom-
binant S. pneumoniae towards the related bacteriocin
enterocin 1071 approximately fourfold (MIC = 1850 nM
without induction to MIC = 475 nM with induction).
Together, these results clearly demonstrate that uppP
expression confers sensitivity to lactococcin G and the
related bacteriocin enterocin 1071.
Discussion
In the present work, whole-genome sequencing of sponta-
neous bacteriocin-resistant mutants has been used to
identify a putative membrane receptor for the two-peptide
bacteriocin lactococcin G. Results from altogether 12 lac-
tococcin G-resistant mutants derived from two separate
sensitive strains unequivocally pointed to UppP/BacA, an
undecaprenyl pyrophosphate phosphatase, as a putative
receptor for this bacteriocin. UppP/BacA participates in the
dephosphorylation of de novo synthesized undecaprenyl
pyrophosphate to undecaprenyl phosphate, the immediate
precursor of lipid I and lipid II in peptidoglycan biosynthesis
(Bickford and Nick, 2013). UppP/BacA is a membrane-
spanning protein with eight putative transmembrane
helices. Most of the detected mutations (9 of 12) resulted in
the production of truncated versions of UppP/BacA
(Table 1 and Fig. 2A). The positions of the truncation sites
in the various mutants span most of the uppP/bacA coding
sequence (Fig. 2A) and lead to the removal of one, two,
three, four, six and seven of the 8 predicted transmem-
brane regions. In two of the lactococcin G-resistant strains
(IL5 and IL6), the uppP open reading frame remained
unaltered, but these strains instead contained changes in
the upstream region of uppP 9 and 77 nucleotides from the
start codon (Fig. 2B). The mutation in IL5, positioned 77
nucleotides upstream from the start codon, is situated
Fig. 3. Quantitative PCR analysis of the uppP expression in
IL1403 and the mutant strains IL3, IL5 and IL6. The uppP levels
are shown as relative values compared to the uppP level in the
wild-type strain IL1403. The values are the average of three
independent runs and the standard deviations are represented by
error bars.
Fig. 4. A. Growth of S. pneumoniae MK194 (encoding a
Zn2+-inducible uppP from L. lactis) in C + Y medium containing
450 nM lactococcin G. Expression of uppP is induced by different
concentrations of Zn2+ in the growth medium. S. pneumoniae
becomes sensitive to lactococcin G when expression of L. lactis
uppP is induced.
B. Control showing the inducing Zn2+ concentrations used did not
significantly alter the growth of S. pneumoniae.
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close to a putative −10 promoter box [predicted by PPP
(Zomer et al., 2007), with an E-value of 0.056], suggesting
that this mutation might have an effect on the uppP tran-
scription level. Indeed, gene-expression analysis by qPCR
verified that the transcription of the uppP gene was
reduced by approximately 20-fold in IL5 compared to the
wild-type strain (Fig. 3). The upstream mutation in IL6 (9 nt
from the start codon) leads to a change in a putative
ribosome binding site for this gene (AGGAGC in the wild-
type changed toAGTAGC in the mutant), which may cause
problems for translation. In addition, one strain (IL3) con-
tained a mutation that leads to an amino acid substitution in
UppP: the exchange of aspartic acid in position 2 with
asparagine. The effect of this substitution on UppP is not
clear. It might interfere with the structure or stability of
UppP, thereby making it less efficient as bacteriocin recep-
tor. However, effects on mRNA secondary structures,
translation regulation, or other unknown effects might also
occur (Keller et al., 2012). No significant change in the
transcription level of uppP was observed in the two mutant
strains IL3 and IL6 (Fig. 3).
Most of the mutations in UppP/BacA gave rise to a very
high level of lactococcin G resistance (Table 1). For
example, all the truncations conferred high degree of
resistance, albeit removal of only the C-terminal trans-
membrane region (IL7) had slightly less effect than trun-
cation of larger parts of the protein. Furthermore, the
mutation in the putative ribosomal binding site (IL6) con-
ferred full resistance, while the mutation adjacent to the
putative −10 promoter region (IL5) only led to partial
resistance. Finally, the change of amino acid in position 2
from aspartic acid to asparagine (IL3) gave partial resist-
ance. Thus, as expected, the mutations with putatively
less severe effect on UppP (promoter point mutation,
single amino acid substitution or deletion of a single trans-
membrane segment) conferred less resistance to lacto-
coccin G.
For unknown reasons, we were not able to clone full-
length uppP in the L. lactis mutants nor in the wild-type. We
also encountered the same problems when trying to use
Escherichia coli as an intermediate host for the lactococcal
vectors. Possibly, these cells are not viable due to the extra
copy of uppP causing imbalance in the cell-wall synthesis
machinery, but this remains to be determined. By heterolo-
gous expression of uppP from L. lactis IL1403 in the
non-sensitive S. pneumoniae, we were able to render S.
pneumoniae sensitive to lactococcin G and enterocin
1071, verifying that the expression of UppP is directly
linked to the sensitivity to lactococcin G and the related
bacteriocin enterocin 1071. The level of sensitivity
observed in S. pneumoniae (MIC = 56 nM) is not compa-
rable to the high sensitivity observed for wild-type L. lactis
(MIC = 0.01 nM). This difference can probably be attrib-
uted to intrinsic resistance mechanisms of S. pneumoniae
(e.g. membrane composition, cell surface properties,
capsule or proteolysis) that makes it more difficult for
lactococcin G to function. Alternatively, there might be a
second, and yet unidentified, factor required for optimal
lactococcin G activity, which is present in L. lactis but not in
S. pneumoniae. It should be noted that S. pneumoniae also
contains an uppP-like gene (locus tag SPD_0417), whose
product is 63% identical to the UppP of L. lactis IL1403
(Fig. S2), but the streptococcal protein does not confer
sensitivity to lactococcin G. Probably, there are specific
regions/residues in the lactococcal UppP/BacA that are
important for the specific recognition of lactococcin G, also
explaining the high specificity of lactococcin G. Future work
should aim at identifying the specific interaction sites
between lactococcin G and UppP/BacA. Importantly, UppP
was also shown to be the target for another class IIb
bacteriocin, namely enterocin 1071 which show 57% iden-
tity to lactococcin G. It should be noted that while lactococ-
cin G sensitivity of S. pneumoniae increased > 50-fold
upon induction of uppP expression, the enterocin 1071
sensitivity increased only fourfold (Table S1). This result is
in line with the observation that enterocin 1071 is also less
effective against L. lactis compared to lactococcin G, pos-
sibly reflecting that UppP from L. lactis is a better target for
lactococcin G than enterocin 1071. Furthermore, it is also
highly likely that lactococcin Q uses UppP as a target, since
this bacteriocin is very similar to lactococcin G (88% iden-
tity) (Zendo et al., 2006).
Together, our results clearly show that the presence of
an intact UppP/BacA is a prerequisite for lactococcin G
sensitivity. As discussed above, it is likely that UppP/BacA
functions as a docking molecule or a receptor for lactococ-
cin G, in which binding of lactococcin G to UppP/BacA
induces pore formation. It could be speculated that one of
the products of UppP/BacA (and not UppP/BacA itself) has
this receptor function, in a similar manner as lipid II which
functions as the receptor for a number of lantibiotic bacte-
riocins, including nisin (Breukink et al., 1999; Wiedemann
et al., 2001; Breukink and de Kruijff, 2006; Bierbaum and
Sahl, 2009). It is improbable, however, that a narrow-
spectrum bacteriocin like lactococcin G uses ubiquitous
membrane molecules, such as undecaprenyl phosphate,
lipid I or lipid II, as receptors or docking molecules. Moreo-
ver, it seems that the products of UppP/BacA are also
present in the lactococcin G-resistant cells in which UppP/
BacA is inactivated, since the lactococcin G-resistant
mutants and the wild-type strains were equally sensitive to
both bacitracin and nisin. The antibiotic bacitracin uses
undecaprenyl pyrophosphate, the substrate molecule for
UppP/BacA, as its membrane receptor (Storm and
Strominger, 1973), while nisin targets lipid II (Breukink
et al., 1999). A drastic reduction in UppP/BacA activity
might therefore be expected to increase the sensitivity to
bacitracin (due to accumulation of undecaprenyl pyroph-
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osphate) (Bernard et al., 2005) and decrease the sensitiv-
ity to nisin (reduced production of lipid II). The facts that this
did not occur and that the growth rates of UppP-inactivated
mutant and wild-type cells were similar indicate that UppP/
BacA is not essential. L. lactis thus probably contain
multiple genes encoding undecaprenyl pyrophosphate
phosphatase activity, similar to what has been shown in E.
coli (El Ghachi et al., 2005). One candidate for such activity
in L. lactis is ykdB (locus tag L32731), which is homologous
to the E. coli proteins YbjG and PgpB, which both have
undecaprenyl pyrophosphate phosphatase activity (El
Ghachi et al., 2005). It could be speculated that the lacto-
coccin G activity towards UppP has been a driving force for
the evolution of redundant undecaprenyl pyrophosphate
phosphatase activity in L. lactis, and more generally, that
protein-targeting bacteriocins is a driver for different gene
duplication events in bacterial evolution. Nevertheless, the
role of these proteins in lactococci needs to be further
investigated since recent results from E. coli suggest that
UppP/BacA has a different physiological role than YbjG
and PgpB; while the former is important for de novo syn-
thesis of undecaprenyl pyrophosphate on the inside of the
cell, the latter proteins rather act on the outside of the
cellular membrane to recycle the lipid carrier (Bickford and
Nick, 2013).
Our results also demonstrate that when used with a
suitable reference genome, the VAAL algorithm (Nusbaum
et al., 2009) was remarkably consistent in calling differ-
ences between the reference genome and Illumina reads.
VAAL called 170 differences between the NC_002662
reference genome and sequence reads from our IL1403
wild-type strain. The same differences were all detected in
each of the IL1403 mutants that we analysed. Besides
these 170 differences, each of the 10 different IL1403
mutants harboured one single point mutation causing the
bacteriocin-resistant phenotype.
In conclusion, we have shown that genome sequencing
and polymorphism detection are sufficient to pinpoint
mutations that are responsible for the bacteriocin-resistant
phenotype and in that way identify the putative bacteriocin
receptor proteins. While lipid II is known as the docking
molecule or receptor for many different lantibiotics
(Breukink and de Kruijff, 2006), the receptors for the class
II non-lantibiotic bacteriocins appear more diverse: the
mannose phosphotransferase system for lactococcin A
(member of class IId) and pediocin-like bacteriocins
(members of class IIa), the maltose-ABC transporter for
garvicin ML (member of class IIc), a membrane-bound
Zn-dependent peptidase for the bacteriocin LsbB (member
of class IId), and here UppP/BacA for lactococcin G and
enterocin 1071 and most probably also lactococcin Q
(members of class IIb). Using the genomics approach
described in this work will probably allow identification of
the receptor for many other bacteriocins in the coming
years and similar approaches can also be used to identify
mutations involved in antibiotic resistance (Wozniak et al.,
2012). The search for novel bacteriocin receptors is an
important research field, not only because it is a critical
aspect in drug development, but also to unravel the little-
understood biological role of bacteriocins in nature, espe-
cially with regard to the ecological impact of their
characteristic, narrow inhibition spectra. One way to shed
light on this important issue is to examine the diversity
of receptors for different bacteriocins, and how the
bacteriocin/receptor/immunity protein interactions affect
the producers, the sensitive target cells and resistant cells
in complex communities, such as in the mammalian gut.
Experimental procedures
Bacterial strains and growth conditions
Lactococcus lactis was grown in GM17-medium [M17-
medium supplemented with 0.4% (w/v) glucose] without
shaking at 30°C. Lactobacillus sakei Lb790 (containing the
two-plasmid system for production of lactococcin G- and
enterocin 1071-peptides) was grown in MRS medium contain-
ing 10 μg ml−1 erythromycin and 10 μg ml−1 chloramphenicol,
without shaking at 30°C. S. pneumoniae was grown in C + Y
medium (Martin et al., 1995) pH 6.8 at 37°C without shaking.
E. coli was grown in LB medium at 37°C with shaking.
Production and purification of bacteriocins
The alpha and beta peptides of lactococcin G and enterocin
1071 were purified from a two-plasmid expression system in
L. sakei Lb790 as previously described (Oppegård et al.,
2007; 2010).
Bacteriocin activity assays
The antimicrobial activity of lactococcin G and enterocin 1071
against sensitive and resistant target cells was tested using a
96-well microtitre plate-based activity assay similarly as pre-
viously described (Oppegård et al., 2007; 2008; 2010). When
measuring the antimicrobial activity of lactococcin G and
enterocin 1071 against wild-type L. lactis IL1403 and L. lactis
subsp. cremoris MG1363 and mutants of these, overnight
(stationary phase) cultures of these cells were diluted about
1:50 in GM17-medium containing 0.1% (v/v) Tween 80, and
200 μl of this cell suspension were added to each well together
with twofold dilutions of the bacteriocin. The microtitre plates
were then incubated for 4–5 h at 30oC before the growth
inhibition was measured spectrophotometrically at 600 nm.
The minimum inhibitory concentration (MIC) is defined as the
peptide concentration [the sum of both peptides (in a 1:1 ratio)]
that inhibited growth by 50%.
Generation of lactococcin G-resistant mutants
The lactococcin G-resistant mutants of L. lactis IL1403 were
generated by slightly different methods. (i) The lactococcin
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G-resistant L. lactis IL1403 mutants termed IL1-IL8 were
generated as follows: a single colony was re-streaked and
several resulting colonies were picked and incubated at 30°C
overnight with 0.05 nM lactococcin G (∼ 5 times MIC). The
overnight cultures were plated on GM17 plates containing
5 nM lactococcin G. After incubation at 30°C overnight, one
single colony was picked from the different plates, resulting in
eight independent lactococcin G-resistant strains (IL1, IL2,
IL3, IL4, IL5, IL6, IL7, IL8). (ii) The lactococcin G-resistant
mutants of L. lactis IL1403 termed IL11 and IL12 were selected
by plating IL1403 on GM17 agar plates containing 10–50 times
MIC of lactococcin G (crude extract). After overnight incuba-
tion, resistant colonies were picked. (iii) For the lactococcin
G-resistant L. lactis subsp. cremoris MG1363 strain, overnight
cultures from two different colonies were diluted 1:50 and
incubated at 30°C for 5 h in a 96-well microtitre plate with
lactococcin G in twofold dilutions. Cells from the well contain-
ing lactococcin G with a concentration corresponding to two
times the MIC-value (∼ 0.05 nM) were harvested. Cultures of
these cells were incubated overnight in GM17 containing 5 nM
lactococcin G for selection of resistance. The overnight cul-
tures were plated on GM17 plates containing 5 nM lactococcin
G, and two independent lactococcin G-resistant colonies were
picked.
Growth and phenotypic assays
For L. lactis, overnight cultures were diluted 100-fold in fresh
medium and growth curves were monitored spectrophoto-
metrically at 600 nm in 96-well microtitre plates using Bio-
screen C (Oy Growth Curves Ab Ltd., Helsinki, Finland). For
S. pneumoniae, cells were grown until OD600 = 0.4, and
diluted 100-fold in fresh medium. Growth curves were moni-
tored spectrophotometrically at 600 nm using Tecan Genios
(Tecan Group, Männedorf, Switzerland).
For sugar fermentation profiles, an API 50 CH kit (bioMé-
rieux, Marcy l’Etoile, France) was used according to the
manufacturer’s protocol.
Isolation of genomic DNA and
whole-genome sequencing
DNA was isolated from 1.5–10 ml overnight cultures of the
sensitive wild-type strains and spontaneous, resistant mutants
using the Qiagen Blood and Tissue Kit (Qiagen N.V., the
Netherlands) according to the producer’s recommendations.
DNA samples were submitted to the Norwegian Sequenc-
ing Centre (sequencing.uio.no). Sequencing was performed
using an Illumina HiSeq instrument, paired-end reads of
2 × 100 – nucleotides and 12× multiplexing according to the
instructions of the manufacturer. These sequence data have
been submitted to the DDBJ/EMBL/GenBank databases
under Accession No. PRJEB5709.
Sequence analysis
The sequence reads were received from the Norwegian
Sequencing Centre as FASTQ files containing the forward and
reverse reads respectively. Due to the high sequence cover-
age, we found it sufficient to use only the forward reads in the
subsequent search for mutations. Before the reads could be
aligned to and compared to the reference genome, the FASTQ
files had to be split into sequence-containing FASTA files and
QUAL files with quality information. The splitting was per-
formed using a simple Biopython script. Then, reads from each
separate resistant mutant and the corresponding sensitive
wild-type strain were compared to the fully annotated data-
base reference genome using the polymorphism discovery
algorithm VAAL from Broad Institute (Nusbaum et al., 2009),
installed on the Abel Computing Cluster at the University of
Oslo. The output from VAAL is a file containing a list of all
observed differences (SNPs or indels) between the sample
genome and the reference genome. Using this list, the variable
sites were identified in the reference genome and assigned to
genes using the genome browsing capabilities of the software
platform Geneious version 6 (created by Biomatters and avail-
able from http://www.geneious.com/).
The upstream region of uppP was scanned for a putative
promoter site using PPP (http://bioinformatics.biol.rug.nl/
websoftware/ppp), in which Hidden Markov models are used
to search for (lactococcal-like) Sigma A binding sites allowing
15 to 19 bp space between the −35 and −10 promoter ele-
ments (Zomer et al., 2007).
Heterologous expression of L. lactis uppP in
S. pneumoniae
The uppP gene was amplified with primers uppP-RBS-F-
BamHI and uppP-R-XbaI (Table S2) using genomic DNA from
L. lactis IL1403 as template. The product was digested with
BamHI and XbaI and ligated into the corresponding sites,
downstream of a Zn2+-inducible promoter in plasmid pJWV102
(J.-W. Veening, unpublished). E. coli was transformed with the
ligation mixture and transformants were selected on LA plates
containing 100 μg ml−1 ampicillin to construct plasmid
pJWV102-uppP. Plasmids were isolated from E. coli using
High Pure Plasmid Isolation Kit (Roche) and checked by PCR
and sequencing. The pJWV102 plasmid contains a tetracy-
cline resistance cassette as well as sequences (flanking the
insert) for integration in the bgaA locus of S. pneumoniae D39.
S. pneumoniae D39 was transformed with pJWV102-uppP
and transformants were selected on Columbia agar supple-
mented with 2% sheep blood and 1 μg ml−1 tetracycline for
selection. Correct insert was verified by PCR. Different con-
centrations of ZnCl2 were added to the growth medium (C + Y)
to induce expression of uppP.
Quantitative PCR
Total RNA was isolated from fresh mid-log cultures of L. lactis
IL1403 and mutants IL3, IL5 and IL6 using the RNeasy kit
(Qiagen), according to the producer’s recommendations,
including the optional DNase treatment. The RNA was stabi-
lized by the addition of RNAprotect Bacteria Reagent
(Qiagen). RNA concentrations were measured using a Nano-
Drop ND2000 spectrophotometer. cDNA was reverse tran-
scribed from 2 μg of total RNA, using the Affinity Script QPCR
cDNA Synthesis kit (Agilent Technologies). Quantitative PCR
(qPCR) was performed on a Lightcycler 96 (Roche), using
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gene-specific primer sets and FASTStart SYBR Green
master (Roche). All measurements were made in triplicates.
As an internal control, 16S rRNA was used (Magnani et al.,
2008). The primers used are listed in Table S2. The following
qPCR-parameters were run: one cycle at 95°C for 600 s
followed by 45 cycles of denaturation at 95°C for 10 s,
annealing at 60°C for 10 s and elongation at 72°C for 10 s.
The three-step amplification was followed by a melting cycle
(95°C for 10 s, 65°C for 60 s and 97°C for 1 s).
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